183 related articles for article (PubMed ID: 11912150)
1. Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer.
Yasuda M; Takenoyama M; Obata Y; Sugaya M; So T; Hanagiri T; Sugio K; Yasumoto K
Cancer Res; 2002 Mar; 62(6):1751-6. PubMed ID: 11912150
[TBL] [Abstract][Full Text] [Related]
2. Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer.
Yasuda M; Mizukami M; Hanagiri T; Shigematsu Y; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(5A):3607-11. PubMed ID: 17094490
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Mizukami M; Hanagiri T; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2005 Dec; 96(12):882-8. PubMed ID: 16367908
[TBL] [Abstract][Full Text] [Related]
4. Effect of IgG produced by tumor-infiltrating B lymphocytes on lung tumor growth.
Mizukami M; Hanagiri T; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; Yasuda M; So T; Takenoyama M; Sugio K; Yasumoto K
Anticancer Res; 2006; 26(3A):1827-31. PubMed ID: 16827114
[TBL] [Abstract][Full Text] [Related]
5. Malignant mesothelioma-associated antigens recognized by tumor-infiltrating B cells and the clinical significance of the antibody titers.
Shigematsu Y; Hanagiri T; Kuroda K; Baba T; Mizukami M; Ichiki Y; Yasuda M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2009 Jul; 100(7):1326-34. PubMed ID: 19432887
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of antibody against a SEREX-defined antigen (UOEH-LC-1) on lung cancer xenotransplanted into severe combined immunodeficiency mice.
Mizukami M; Hanagiri T; Yasuda M; Kuroda K; Shigematsu Y; Baba T; Fukuyama T; Nagata Y; So T; Ichiki Y; Sugaya M; So T; Takenoyama M; Sugio K; Yasumoto K
Cancer Res; 2007 Sep; 67(17):8351-7. PubMed ID: 17804751
[TBL] [Abstract][Full Text] [Related]
7. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating B-cell-derived IgG recognizes tumor components in human lung cancer.
Imahayashi S; Ichiyoshi Y; Yoshino I; Eifuku R; Takenoyama M; Yasumoto K
Cancer Invest; 2000; 18(6):530-6. PubMed ID: 10923101
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
[TBL] [Abstract][Full Text] [Related]
10. An MVA vaccine overcomes tolerance to human p53 in mice and humans.
Song GY; Gibson G; Haq W; Huang EC; Srivasta T; Hollstein M; Daftarian P; Wang Z; Diamond D; Ellenhorn JD
Cancer Immunol Immunother; 2007 Aug; 56(8):1193-205. PubMed ID: 17219151
[TBL] [Abstract][Full Text] [Related]
11. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
[TBL] [Abstract][Full Text] [Related]
12. Engraftment of human tumor-infiltrating lymphocytes and the production of anti-tumor antibodies in SCID mice.
Williams SS; Chen FA; Kida H; Yokata S; Miya K; Kato M; Barcos MP; Wang HQ; Alosco T; Umemoto T; Croy BA; Repasky EA; Bankert RB
J Immunol; 1996 Mar; 156(5):1908-15. PubMed ID: 8596043
[TBL] [Abstract][Full Text] [Related]
13. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
14. B cell response to tumor antigens is associated with depletion of B progenitors in murine colocarcinoma.
Kirman I; Huang EH; Whelan RL
Surgery; 2004 Mar; 135(3):313-8. PubMed ID: 14976482
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
16. Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity.
Kennedy RC; Shearer MH; Lowe DB; Jumper CA; Chiriva-Internati M; Bright RK
Cancer Immunol Immunother; 2004 Nov; 53(11):987-94. PubMed ID: 15156293
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
18. Identification of DR9-restricted XAGE antigen on lung adenocarcinoma recognized by autologous CD4 T-cells.
Shimono M; Uenaka A; Noguchi Y; Sato S; Okumura H; Nakagawa K; Kiura K; Tanimoto M; Nakayama E
Int J Oncol; 2007 Apr; 30(4):835-40. PubMed ID: 17332921
[TBL] [Abstract][Full Text] [Related]
19. [Screening and identification of human lung cancer-related antigens].
Liu HY; Peng LP; Ran YL; Zhang LZ; Zhang DC; Zhu YK; Yang ZH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):171-5. PubMed ID: 12006991
[TBL] [Abstract][Full Text] [Related]
20. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
Nagata Y; Hanagiri T; Takenoyama M; Fukuyama T; Mizukami M; So T; Ichiki Y; Sugaya M; Sugio K; Yasumoto K
Clin Cancer Res; 2005 Jul; 11(14):5265-72. PubMed ID: 16033845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
